(Press-News.org) CHICAGO --- A new gentler chemotherapy drug in the form of nanoparticles has been designed by Northwestern Medicine® scientists to be less toxic to a young woman's fertility but extra tough on cancer. This is the first cancer drug tested while in development for its effect on fertility using a novel in vitro test.
The scientists designed a quick new in vitro test that predicts the toxicity of a chemotherapy drug to fertility and can be easily used to test other cancer drugs in development as well as existing ones. Currently the testing of cancer drugs for fertility toxicity is a time and resource intensive process.
"Our overall goal is to create smart drugs that kill the cancer but don't cause sterility in young women," said Teresa Woodruff, a co-principal investigator of the study and chief of fertility preservation at Northwestern University Feinberg School of Medicine. The paper was published March 20 in in the journal PLOS ONE.
The scientists hope their integration of drug development and reproductive toxicity testing is the beginning of a new era in which chemotherapy drugs are developed with an eye on their fertotoxity (fertility toxicity). As cancer survival rates increase, the effect of cancer treatments on fertility is critically important to many young patients.
Woodruff and Thomas O'Halloran, also a co-principal investigator and director of the Chemistry of Life Processes Institute at Northwestern, are a wife and husband team who developed and tested the drug. Their intersecting interests -- hers in fertility preservation, his in cancer drug development -- percolated over dinner conversations and sparked the collaboration.
O'Halloran also is the associate director for basic sciences research at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Woodruff is the Thomas J. Watkins Memorial Professor of Obstetrics and Gynecology at Feinberg. Richard Ahn, now a fourth-year medical student at Feinberg in the M.D.-PhD program and the study's lead author, coordinated the preclinical testing of the nanobins as a graduate student in O'Halloran's lab.
A Tiny Trojan Horse
The chemotherapy drug, arsenic trioxide, is packed into a very tiny Trojan horse called a nanobin. The nanobin consists of nano-size crystalline arsenic particles densely packed and encapsulated in a fat bubble. The fat bubble, a liposome, disguises the deadly cargo -- half a million drug molecules.
"You have to wallop the tumor with a significant dose of arsenic but at the same time prevent exposure to normal tissue from the drug," said O'Halloran. The fat bubble is hundreds of times smaller than the average human cell. It is the perfect size to stealthily slip through holes in the leaky blood vessels that rapidly grow to feed tumors. The local environment of the tumor is often slightly acid; it is this acid that causes the nanobin to release its drug cargo and deliver a highly effective dose of arsenic where it is needed.
The scientists show this approach to packaging and delivering the active drug has the desired effect on the tumor cells but prevents damage to ovarian tissue, follicles or eggs.
While the drug is gentle on fertility, it is ferocious on cancer. When tested against lymphoma, it was more potent than the drug in its traditional free form.
"The drug was designed to maximize its effectiveness but reduce fertotoxicity," said O'Halloran, also the Morrison Professor of Chemistry in the Weinberg College of Arts and Sciences at Northwestern. "Many cancer drugs cause sterilization, that's why the reproductive tract is really important to focus on in the new stages of drug design. Other body systems get better when people stop taking the drug, but fertility you can't recover."
Arsenic trioxide was approved a few years ago for treating some types of blood cancers such as leukemia in humans, but O'Halloran thinks the arsenic trioxide nanobins can be used against breast cancer and other solid tumors. In his previously published preclinical research, nanobins were effective in reducing tumor growth in triple-negative breast cancer, which often doesn't respond well to traditional chemotherapy and has a poor survival rate.
Quick Test For Fertility Toxicity
Woodruff was able to show early effects of the drug on fertility by using an in vitro follicle culture and a quick, simple new test she developed. She compared the fertotoxicity of the nanobin and free drug and found the nanobin was much less toxic to female fertility than the free drug in the experimental model.
"The system can be adapted very easily for any cancer drug under development to get an early peek under the tent,"said Woodruff, also the Thomas J. Watkins Memorial Professor of Obstetrics and Gynecology at Feinberg. "As this new drug goes forward in development, we can say this is a good drug for young female cancer patients who are concerned about fertility."
The information gained from the toxicity test will help inform the treatment decisions of oncologists and their young female cancer patients to improve their chances of creating a future family.
"They may prescribe less toxic drug regimens or refer them to specialists in fertility preservation," Woodruff said.
###
The research was supported by grants RL1HD058295, PL1EB008542 and T32 HD07068 from the National Institute of Child Health and Development of the National Institutes of Health; grants U01CA151461, U54CA119341 and P30CA060553 from the National Cancer Institute of the National Institutes of Health; and grant BC073413 from the Department of Defense. END
A team of scientists from the Johns Hopkins University Applied Physics Laboratory (APL) has developed a novel method to accurately predict dengue fever outbreaks several weeks before they occur.
The new method, known as PRedicting Infectious Disease Scalable Model (PRISM), extracts relationships between clinical, meteorological, climatic and socio-political data in Peru and in the Philippines. It can be used in any geographical region and extended to other environmentally influenced infections affecting public health and military forces worldwide.
PRISM is aimed ...
Scientists have discovered a layer of liquified molten rock in Earth's mantle that may be responsible for the sliding motions of the planet's massive tectonic plates.
The finding may carry far-reaching implications, from understanding basic geologic functions of the planet to new insights into volcanism and earthquakes.
The research was funded by the National Science Foundation (NSF), and is reported in this week's issue of the journal Nature by Samer Naif, Kerry Key, and Steven Constable of the Scripps Institution of Oceanography (SIO), and Rob Evans of the Woods ...
DENVER – Molecular driven therapeutic targets have resulted in a paradigm shift in the treatment of advanced lung adenocarcinoma. However, in early non-small cell lung cancer (NSCLC), surgical resection remains the treatment of choice with adjuvant chemotherapy. In a recent study published in the April 2013 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, researchers identified patterns of mutations in early stage node negative lung adenocarcinoma.
They retrospectively reviewed 204 patients with stage IB primary ...
Sunghwan Jung is a fan of the 19th Century born John William Strutt, 3rd, also known as Lord Baron Rayleigh. An English physicist, Rayleigh, along with William Ramsay, discovered the gas argon, an achievement for which he earned the Nobel Prize for Physics in 1904.
But it was Rayleigh's lesser-known discovery of a physical phenomenon in 1878 that was more intriguing to Jung. Some 135 years ago, Rayleigh wrote that two fluid jets or drops do not always merge into one body of liquid, a counter-intuitive topic or phenomena in physics that has since been studied in much detail, ...
Atherosclerosis, an inflammatory reaction, is at the root of the most common forms of cardiovascular disease. Researchers at Ludwig-Maximilians-Universitaet (LMU) in Munich have now identified a microRNA that plays a prominent role in the process, and offers a promising target for new therapies.
Atherosclerosis – otherwise known as hardening of the arteries – is a prevalent cause of death in modern societies. The condition arises from the build-up of localized fatty deposits called plaques in the arteries. Macrophages, the phagocytic cells of the immune system, migrate ...
Philadelphia, PA, March 22, 2013 – The prevalence of obesity within the military is currently 13 percent. This rising epidemic, also rampant throughout the general population, could result in military career setbacks, negatively impact operational readiness, and jeopardize Department of Defense operations. To combat the epidemic, a team of researchers chose the military cafeteria as the venue to observe and evaluate eating behavior and the positive impact of modest changes to promote healthy eating and food selection. The results are captured in a new report published by ...
Catching rides on cargo ships and fishing boats, many invasive species are now covering our shorelines and compromising the existence of our native marine life.
In a study published in Ecology Letters, Northeastern University Prof. David Kimbro and his team examine what factors allow some invasive species to survive in their new environments and others to fail.
WHY SHOULD WE CARE?
Once invasive species arrive in their new location, they begin multiplying, and in some cases, overpowering the local marine life. This can have a very strong impact on our ecosystems and ...
Certain Streptococci increase their production of toxic shock syndrome toxin 1, sometimes to potentially dangerous levels, when aerobic bacteria are present in the vagina. But scientists from the University of Western Ontario have discovered certain strains of lactobacillus bacteria are capable of dampening production of that toxin according to research published in the journal Applied and Environmental Microbiology.
"The risk of potentially fatal toxic shock syndrome appears to be influenced by the types of bacteria present in the vagina," says principal investigator ...
Contact: Coimbra Sirica
csirica@burnesscommunications.com
52-155-215-38038
Angélica Zambrano
anyelik.zam@gmail.com
571-510-55-53
Burness Communications
Study shows resources giveaway in Latin America; Outdated model tramples human rights, environment
Researcher points to 'colonial mentality' as governments race to attract investors; Cites destruction of forests, rivers, way of life of rural communities in 4 nations
BOGOTÁ, COLOMBIA (21 March 2013)—A new study reveals that governments in Latin America have returned to natural resources extraction to fuel ...
PHILADELPHIA (March 22, 2013)— One molecule makes nerve cells grow longer. Another one makes them grow branches. These new experimental manipulations have taken researchers a step closer to understanding how nerve cells are repaired at their farthest reaches after injury. The research was recently published in the Journal of Neuroscience.
"If you injure a peripheral nerve, it will spontaneously regenerate, but it goes very slowly. We're trying to speed that up," said Dr. Jeffery Twiss, a professor and head of the biology department at Drexel University in the College of ...
